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EDITORIAL
A New Vision for the National Institutes of Health
Elias A. Zerhouni, MD∗
National Institutes of Health, 1 Center Drive, Bethesda, MD 20892, USA
The National Institutes of Health (NIH) has grown
from a one-room bacteriology laboratory in 1887 into a
multibillion-dollar medical research enterprise. While the
NIH has remained true to its original mission—pursuing
scientiﬁc knowledge to improve people’s health—almost
everything else about it has changed.
Today, NIH comprises 27 Institutes and Centers that
sponsor medical research in areas ranging from cancer to
diabetes and from genomics to alternative medicine.
With the dramatic increases in scientiﬁc knowledge
as well as the signiﬁcant changes in diagnosis, treatment,
prevention, translation, and delivery of care, researchers
must continue to meet the challenges of tomorrow by
adopting new strategies today.
The NIH is pioneering a vision that will determine
what the agency should be and should do in this new
“biomedical century.” We are focusing our research en-
ergies in three speciﬁc areas: exploiting new pathways of
discovery; encouraging the formation of interdisciplinary
teams of the future; and reengineering the clinical re-
search enterprise.
In the ﬁrst area, we know that scientiﬁc research is
cost-eﬀective because it saves lives and money in both the
short and the long run. Witness our successes in working
with AIDS, coronary heart disease, and cancer. We also
know that health care costs are continuing to spiral up-
ward, partly due to the aging population which is placing
more and more demands on the system.
To keep up with the projected increases in costs, the
research enterprise must not only accelerate the pace of
discovery, but also apply its research results in a timely
manner. I believe this is one of the greatest challenges we
face in this biomedical century.
In the second area, discoveries in human biology are
occurring at unprecedented speed, presenting opportuni-
ties in medicine that we could only dream about just a few
years ago. But these opportunities require a shift in how
medical research is conducted and funded.
While investigator-initiated projects are the mainstay
ofNIH-supportedresearch,increasinglytheseprojectsin-
volve larger multidisciplinary teams of scientists. These
teamsmightinclude specialistsin disciplines outsidebiol-
ogy, such as computer science, imaging, chemistry, math-
ematics, and informatics. Such multidisciplinary science
teams are the wave of the future.
I believe that we need to break down the walls that ex-
ist between scientiﬁc disciplines, inside and outside NIH.
We need to foster the growth of interdisciplinary teams in
order to maximize the enormous potential of research to
improve our lives.
For its part, NIH is working to meet this challenge
by ﬁlling leadership positions at its Institutes and Centers
with outstanding scientists who have experience with this
new paradigm.
In the third area, we need to reengineer the national
clinical research enterprise in order to most eﬀectively
translate our discoveries into clinical reality. The list of
initiatives to undertake is long, but necessary. It includes
supporting multidisciplinary clinical research training ca-
reer paths, introducing innovations in trial design, stim-
ulating translational research, building clinical resources
like tissue banks, developing large clinical research net-
works, and reducing regulatory hurdles. We must also
explore a standard clinical research informatics strategy,
which will permit the formation of Nation-wide “com-
munities” of clinical researchers made up of academic
researchers, qualiﬁed community physicians, and patient
groups.
Alongside our dedicated eﬀorts to pioneer a new vi-
sion for NIH is the continuing need to attract the best
and brightest researchers. We in the scientiﬁc commu-
nity realize the need to cultivate and nurture minority
talent if scientiﬁc research is to remain a viable enter-
prise. Currently, we are experiencing diﬃculty in retain-
ingresearchersfromtheminoritycommunities,especially
through the doctoral levels.
We must identify and attract students with potential
early on and not let them “fall through the cracks” of
academia. We need to consider novel approaches to en-
courage minority students to remain in mainstream sci-
ence. Providing students with knowledgeable and sup-
p o r t i v em e n t o r sa n dr o l em o d e l sc o u l ds e r v ea sa ne n t i c e -
ment.
NIH has been a leader in supporting minority stu-
dents throughout their education, with numerous pro-
grams and policies in place to increase the number of160 Elias A. Zerhouni, MD 2003:3 (2003)
minorities in research careers. As we take on the challenge
of conducting scientiﬁc research in the 21st century by
pursuing the NIH vision, it is absolutely critical that we
ﬁnd ways to recruit and retain more women and minori-
ties in scientiﬁc careers.
Elias A. Zerhouni, MD
Elias A. Zerhouni began his tenure as
the 15th Director of the National In-
stitutes of Health on May 20, 2002. Dr
Zerhouni initiated the creation of a new
research vision for the NIH which fo-
cuses the attention of the biomedical re-
search community on new pathways of
discovery, research teams for the future,
and the reengineering of the clinical re-
search enterprise. Among his noteworthy achievements since
becoming Director, Dr Zerhouni has named directors for three
institutes—the National Institute of Mental Health (Thomas
R. Insel, MD), the National Institute on Alcohol Abuse and
Alcoholism (Ting-Kai Li, MD), and the National Institute on
Drug Abuse (Nora D. Volkow, MD). He also named a new NIH
Deputy Director (Raynard S. Kington, MD, PhD) and a new di-
rectoroftheOﬃceofTechnologyTransfer(MarkL.Rohrbaugh,
PhD, JD) He has also overseen the completion of the doubling
of the NIH budget during the last ﬁve years. His research in
imaging led to advances in Computerized Axial Tomography
(CAT scanning) and Magnetic Resonance Imaging (MRI) that
resulted in 157 peer reviewed publications and 8 patents.
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